Cholinesterases

Hayes' Handbook of Pesticide Toxicology

Volumn , Issue , 2010, Pages 1457-1478

  Wilson, Barry W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 81455137291     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-374367-1.00068-9     Document Type: Chapter

References (181)

1. Abderhalden E., Paffrath H. Beitrag der Frage der Inkret(Hormon)-Wirkung aud die motorischen Funktionen des Ver-dauungskanales V. Uber die synthese von cholinestern aus Cholin und Fettsauren mittels Fermenten des Dunndarm. Fermentforsch 1925, 8:299.
2. Abernathy M.H., Fitzgerald H.P., Ahern K.M. An enzymatic method for erythrocyte acetylcholinesterase. Clin. Chem. 1988, 34:1055-1057.
3. Abou-Donia M.B., Wilmarth K.R., Abdel-Rahman A.A., Jensen K.F., Oehme F.W., Kurt T.L. Increased neurotoxicity following concurrent exposure to pyridostigmine bromide, DEET, and chlorpyrifos. Fundam. Appl. Toxicol. 1996, 34:201-222.
4. Abou-Donia M.B., Wilmarth K.R., Jensen K.F., Oehme F.W., Kurt T.L. Neurotoxicity resulting from coexposure to pyridostigmine bromide, DEET, and permethrin; Implications of Gulf War chemical exposures. J. Toxicol. Environ. Health 1996, 48:35-56.
5. Albuquerque E.X., Pereira E.F., Braga M.F., Alkondon M. Contribution of nicotinic receptors to the function of synapses in the central nervous system, the action of choline as a selective agonist of alpha 7 receptors. J. Physiol. (Paris) 1998, 92:309-316.
6. Aldridge W.N., Reiner E. Enzyme Inhibitors as Substrates 1972, North-Holland/Elsevier, Amsterdam.
7. Alkondon M., Pereira E.F., Cortes W.S., Maelicke A., Albuquerque E.X. Choline is a selective agonist of alpha7 nicotinic acetylcholine receptors in the rat brain neurons. Eur. J. Neurosci. 1997, 12:2734-2742.
8. Amaya A., Keifer M., McConnell R. Comment on EQM Testmate OP cholinesterase kit. Occup. Environ. Med. 1996, 53:358.
9. Ammon R. Die fermentative spaltung des acetylcholins. Arch. ges. Physiol. Menschen Tiere, 1933, 233:486-491.
10. Anderson R.B., Key B. Role of acetylcholinesterase in the development of axon tracts within the embryonic vertebrate brain. Int. J. Dev. Neurosci. 1999, 17:787-793.
11. Atkinson J.E., Bolte H.F., Rubin L.F., Sonawane M. Assessment of ocular toxicity in dogs during 6 months' exposure to a potent organophosphate. J. Appl. Toxicol. 1994, 14:145-152.
12. Augustinsson K.-B. Cholinesterases, a study in comparative enzymology. Acta Physiol. Scand. 1948, 15(Suppl 52):1-182.
13. Augustinsson K.-B. Electrophoresis studies on blood plasma esterases: I. Mammalian plasmata. Acta Chem. Scand. 1959, 13:571-592.
14. Augustinsson K.-B. Electrophoresis studies on blood plasma esterases: II. Avian, reptilian, amphibian and piscine plasmata. Acta Chem. Scand. 1959, 13:1081-1096.
15. Augustinsson K.-B., Eriksson H., Faijersson Y. A new approach to determining cholinesterase activities in samples of whole blood. Clin. Chim. Acta 1978, 89:239-252.
16. Austin L., Berry W.K. Two selective inhibitors of cholinesterase. Biochem. J. 1953, 54:695-700.
17. Ballantyne B., Marrs T.C. Clinical and Experimental Toxicology of Organophosphates and Carbamates" 1992, Butterworth-Heinemann, Oxford.
18. Bartels C.F., Xie W., Miller-Lindholm A.K., Schopfer L.M., Lockridge O. Determination of the DNA sequences of acetylcholinesterase and butyrylcholinesterase from cat and demonstration of the existence of both in cat plasma. Biochem. Pharmacol. 2000, 60(4):479-487.
19. Beaman J.R., Finch R., Gardner H., Hoffmann F., Rosencrance A., Zelikoff J.T. Mammalian immunoassays for predicting the toxicity of malathion in a laboratory fish model. J. Toxicol. Environ. Health 1999, 56:523-542.
20. Bellino M., Ficarra M., Frontali N., Ghezzo F., Guarcini A.M., Orecchio F., Serpietri L.A., Traina M.E. A quick and simple method for the routine determination of acetyl- and butyrylcholinesterase in blood. Br. J. Ind. Med. 1978, 35:161-167.
21. Reagentet cholinesterase 124117 1981, Boehringer Mannheim Diagnostics, Boehringer Mannheim Diagnostics Division, Indianapolis, IN.
22. Boyce C.P. Comparison of approaches for developing distributions for carcinogenic slope factors. Hum. Ecol. Risk Assess. 1998, 4(2):527-577.
23. Boyer A.C., Brown L.J., Slomka M.B., Hine C.H. Inhibition of human plasma cholinesterase by ingested dichlorvos, effect of formulation vehicle. Toxicol. Appl. Pharmacol. 1977, 41:389-394.
24. Boyes W.K., Tandon P., Barone S., Padilla S. Effects of organophosphates on the visual system of rats. J. Appl. Toxicol. 1994, 14:135-143.
25. Brimijoin S. Enzymology and biology of cholinesterases. Proceedings of the U.S. EPA Workshop on Cholinesterase Methodo-logies, 1992, 30. U.S. Environmental Protection Agency, Washington, DC.
26. Burruel V.R., Raabe O.G., Overstreet J.W., Wilson B.W., Wiley L.M. Paternal effects from methamidophos administration in mice. Toxicol. Appl. Pharmacol. 2000, 165:148-157.
27. Camara A.L., Braga M.F., Rocha E.S., Santos M.D., Cortes W.S., Cintra W.M., Aracava Y., Maelicke A., Albuquerque E.X. Methamidophos, an anticholinesterase without significant effects on postsynaptic receptors or transmitter release. Neurotoxicology 1997, 18:589-602.
28. Carakostas M.C., Landis M.A. Modification of an automated method for determining plasma and erythrocyte cholinesterase activity in laboratory animals. Vet. Hum. Toxicol. 1991, 33:450-456.
29. Carlock L.L., Chen W.L., Gordon E.B., Killeen J.C., Manley A., Meyer L.S., Mullin L.S., Pendino K.J., Percy A., Sargent D.E., Seaman L.R., Svanborg N.K., Stanton R.H., Tellone C.I., Van Goethem D.L. Regulating and assessing risks of cholinesterase-inhibiting pesticides, divergent approaches and interpretations. J. Toxicol. Environ. Health B 1999, 2:105-160.
30. Organophosphates: Chemistry, Fate, and Effects 1992, Academic Press, New York. J.E.,. Chambers, P.E. Levi (Eds.).
31. Chancy L.A., Wineman R.W., Rockhold R.W., Hume R.S. Acute effects of an insect repellant, N,N-diethyl-m-toluamide, on cholinesterase inhibition induced by pyridostigmine bromide in rats. Toxicol. Appl. Pharmacol. 2000, 165:107-114.
32. Chen J.-W., Ling K.-H. Territrems, naturally occurring specific irreversible inhibitors of acetylcholinesterase. J. Biomed. Sci. 1996, 3:54-58.
33. Chiappa S., Brimijoin S. Pharmacologic tests of a role for acetylcholinesterase in promoting neurite outgrowth by dorsal root ganglia. Structure and Function of Cholinesterases and Related Proteins 1998, 585-592. Plenum, New York. B.P. Doctor (Ed.).
34. Christenson W.R., Van Goethem D.L., Schroeder R.S., Wahle B.S., Dass P.D., Sangha G.K., Thyssen J.H. Interlaboratory comparison determinations and the effect on the results of statistical evaluation of cholinesterase inhibition. Toxicol. Lett. 1994, 71(2):139-150.
35. Collombel C., Perrot L. Determination of the cholinesterase activity of whole blood removed by pricking the skin and deposited on filter paper. Application to the detection of organophosphorus insecticide poisonings. J. Eur. Toxicol 1970, 3:368-372.
36. Corrado M.U.D., Politi H., Trielli F., Angelini C., Falugi C. Evidence for the presence of a mammalian-like cholinesterase in Paramecium primaurelia (Protista, Ciliophora) developmental cycle. J. Exp. Zool. 1999, 283(1):102-105.
37. Corrado M.U.D., Trielli F., Amaroli A., Ognibene M., Falugi C. Protists as tools for environmental biomonitoring: Importance of cholinesterase enzyme activities. Water Pollution: New Research 2005, 1-20. Nova Science, Hauppauge, NY. F. Columbus, (Ed.).
38. 1 flanking region of ace-1, the gene encoding acetylcholinesterase of class A in Caenorhabditis elegans. J. Mol. Biol. 1999, 290:951-966.
39. Dahlgren, E. (1983). Recent research in Sweden on chemical detection. In "Proceedings of the International Symposium on Protection against Chemical Warfare Agents," FOA report No. C 40171-C2, C3, pp. 77-82. National Defense Research Institute, Umea, Sweden.
40. Dale H.H. The action of certain esters and ethers of choline and their relation to muscarine. J. Pharmacol. Exp. Ther. 1914, 6:147-190.
41. De la Hoz D., Doctor B.P., Ralston J.S., Rush R.S., Wolfe A.D. A simplified procedure for the purification of large quantities of fetal bovine serum acetylcholinesterase. Life Sci. 1986, 39:195-199.
42. Dementi B. Ocular effects of organophosphates, a historical perspective of Saku disease. J. Appl. Toxicol. 1994, 14:119-129.
43. Dettbarn W.D. Pesticide induced muscle necrosis: Mechanisms and prevention. Fundam. Appl. Toxicol. 1984, 4(2 Pt 2):S18-S26.
44. Doctor B.P., Raveh L., Wolfe A.D., Maxwell D.M., Ashani Y. Enzymes as pretreatment drugs for organophosphate toxicity. Neurosci. Biobehav. Rev. 1991, 15:123-128.
45. Doctor B.P., Taylor P., Quinn D.M., Rotundo R.L., Gentry M.K. Structure arid Function of Cholinesterases and Related Proteins 1998, Plenum, New York.
46. Doctor B.P., Toker L., Roth E., Silman I. Microtiter assay for acetylcholinesterase. Anal. Biochem. 1987, 166:399-403.
47. Ecobichon D.J. Toxic effects of pesticides. Cassarett and Doull's Toxicology 1996, 655-666. McGraw-Hill, New York. 5th ed. C.D. Klassen (Ed.).
48. Ellman G.L., Courtney K.D., Andres V., Featherstone R.M. A new rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 1961, 7:88-95.
49. Engelhart E., Loewi O. Fermentative azetylcholinspaltung im blut und ihre hemmung. Naunyn-Schiedeberg's Arch. Exp. Pathol. Pharmakol. 1930, 150:1-13.
50. Faerman C., Ripoll D., Bon S., Le Feuvre Y., Morel N., Massoulie J., Sussman J.L., Silman I. Site-directed mutants designed to test back-door hypotheses of acetylcholinesterase function. FEBS Lett. 1996, 386:65-71.
51. Francis P.T., Palmer A.M., Snape M., Wilcock G.K. The cholinergic hypothesis of Alzheimer's disease, a review of progress. J. Neurol. Neurosurg. Psychiatr. 1999, 66:137-147.
52. Furlong C.E., Li W.-F., Richtei R.J., Shih D.M., Lusis A.J., Alleva E., Costa L.G. Genetic and temporal determinants of pesticide sensitivity, role of paraoxonase (PON1). Neurotoxicology 2000, 21(1/2):91-100.
53. Gage J.C. The significance of blood cholinesterase activity measurements. Residue Rev. 1967, 18:159-173.
54. Gallo M.A., Lawryk N.J. Organic phosphorus pesticides. Handbook of Pesticide Toxicology 1991, 917-1123. Academic Press, New York. W.J. Hayes, E.R. Laws (Eds.).
55. Gamson R.M., Robinson D.W., Goodman A. Test for anticholinesterase materials in water. Environ. Sci. Technol. 1973, 7:1137-1140.
56. Geller A.M., Abdel-Rahman A.A., Peiffer R.L., Abou-Donia M.B., Boyes W.K. The organophosphate pesticide chlorpyrifos affects form deprivation myopia. Investigative Ophthalmol. Visual Sci. 1998, 39:1290-1294.
57. Gnatt A., Lowenstein Y., Yaron A., Schwarz M., Soreq H. Site-directed mutagenesis of active site residues reveals plasticity of human butyrylcholinesterase in substrate and inhibitor interactions. J. Neurochem. 1994, 62:749-755.
58. Groff W.A., Kaminskis A., Ellin R.I. Interconversion of cholinesterase enzyme activity units by the manual pH method and recommended automated method. Clin. Toxicol. 1976, 9:353-358.
59. Gupta P.K., Roy J.K., Prasad M. DNA chips, microarrays and genomics. Curr. Sci. 1999, 77:875-884.
60. Haley R.W., Billecke S., LaDu B.N. Association of low PON1 Type Q (Type A) arylesterase activity with neurologic symptom complexes in Gulf War veterans. Toxicol. Appl. Pharmacol. 1999, 157:227-233.
61. Hamm J.T., Wilson B.W., Hinton D.E. Organophosphate-induced acetylcholinesterase inhibition and embryonic retinal cell necrosis in vivo in the teleost (Oryzias latipes). Neurotoxicology 1998, 19:853-869.
62. Hansen M.E., Wilson B.W. Oxime reactivation of RBC acetylcholinesterases for biomonitoring. Arch. Environ. Contam. Toxicol. 1999, 37:283-289.
63. Harlin K.S., Ross P.F. Enzymatic-spectrophotometric method for determination of cholinesterase activity in whole blood, collaborative study. J. Assoc. Off. Anal. Chem. 1990, 73:616-619.
64. Henn B.C., McMaster S., Padilla S. Measuring cholinesterase activity in human saliva. J. Toxicol. Environ. Health A 2006, 69(19):1805-1818.
65. Hestrin S. The reaction of acetylcholine and other carboxylic acid derivatives with hydroxylamine, and its analytical application. J. Biol. Chem. 1949, 180:249-261.
66. Hille T., Mueller W., Asmussen B., Levy A., Meshulam Y. Pharmaceutical formulation for prophylaxis or preliminary treatment against poisoning by organophosphorus cholinesterase inhibitors. Ger. Offen. 1995, 6.
67. Hoffman R.S., Henry G.C., Wax P.M., Weisman R.S., Howland M.A., Goldfrank L.R. Decreased plasma cholinesterase activity enhances cocaine toxicity in mice. J. Pharmacol. Exp. Ther. 1992, 263:698-702.
68. Hoffmann W.E., Kramer J., Main A.R., Torres J.L. Clinical enzymology. The Clinical Chemistry of Laboratory Animals 1989, 217-278. Pergamon, New York. W.F. Loeb, F.W. Quimby (Eds.).
69. Holmstedt B. A modification of the thiocholine method for the determination of cholinesterase: I. Biochemical evaluation of selective inhibitors. Acta Physiol. Scand. 1957, 40:322-330.
70. Holmstedt B. Structure-activity relationships of the organophosphorus anticholinesterase agents. Cholinesterases and Anticholinesterase Agents: Handbuch der Experimentellen Pharmakologie 1963, Vol. 15:428-485. Springer-Verlag, Berlin. G.B. Koelle, (Ed.).
71. Humiston C.G., Wright G.W. An automated method for the determination of cholinesterase activity. Toxicol. Appl. Pharmacol. 1967, 10:467-480.
72. Husain K. Phenylvalerate and choline ester hydrolases in the platelets of human, hen, rat and mouse. Hum. Exp. Toxicol. 1994, 13:157-159.
73. Jaga K., Dharmani C. Ocular toxicity from pesticide exposure: A recent review. Environ. Health Prev. Med. 2006, 11(3):102-107.
74. Johnson C.D., Russell R.L. Rapid simple radiometric assay for cholinesterase, suitable for multiple determinations. Anal. Biochem. 1975, 64(1):229-238.
75. Kasprzak H., Salpeter M.M. Recovery of acetylcholinesterase at intact neuromuscular junctions after in vivo inactivation with diisopropylfluorophosphate. J. Neurosci. 1985, 5:951-955.
76. Katz E.J., Cortes V.I., Eldefrawi M.E., Eldefrawi A.T. Chlorpyrifos, parathion, and their oxons bind to and desensitize a nicotinic acetylcholine receptor; Relevance to their toxicities. Toxicol. Appl. Pharmacol. 1997, 146:227-236.
77. Keifer M., Rivas F., Moon J.D., Checkoway H. Symptoms and cholinesterase activity among rural residents living near cotton fields in Nicaragua. Occup. Environ. Med. 1996, 53:726-729.
78. Koelle G.B. Cholinesterases and Anticholinesterase Agents: Handbuch der Experimentellen Pharmakologie. 1963, Vol. 15. Springer-Verlag, Berlin.
79. Krasowski M.D., McGehee D.S., Moss J. Natural inhibitors of cholinesterases; Implications for adverse drug reactions. Can. J. Anaesth. 1997, 44(5 Pt 1):525-534.
80. Krejci E. The building of acetylcholinesterase collagen-tailed forms. Structure and Function of Cholinesterases and Related Proteins 1998, 57-63. Plenum, New York. B.P. Doctor (Ed.).
81. Kurt T.L. Epidemiological association in U.S. veterans between Gulf War illness and exposures to anticholinesterases. Toxicol. Lett. 1998, 102/103:523-526.
82. La Du B.N., Aviram M., Billecke S., Navab M., Primo-Parmo S., Sorenson R.C., Standiford T.J. On the physiological role(s) of the paraoxonases. Chem. Biol. Interact. 1999, 119/120:379-388.
83. Layer P.G., Keller M., Mack A., Willbold E., Robitzki A. Nonenzymatic roles of cholinesterases in avian neurogenesis. Structure and Function of Cholinesterases and Related Proteins 1998, 569-576. Plenum, New York. B.P. Doctor (Ed.).
84. Leonard J.P., Salpeter M.M. Agonist-induced myopathy at the neuromuscular junction is mediated by calcium. J. Cell Biol. 1979, 82:811-819.
85. Li B., Stribley J.A., Ticu A., Xie W., Schopfer L.M., Hammond P., Brimijoin S., Hinrichs S.H., Lockridge O. Abundant tissue butyrylcholinesterase and its possible function in the acetylcholinesterase knockout mouse. J. Neurochem. 2000, 75(3):1320-1331.
86. Li W.F., Furlong C.E., Costa L.G. Paraoxonase protects against chlorpyrifos toxicity in mice. Toxicol. Lett. 1995, 76:219-226.
87. Loewi O., Navratil E. Uber humorale Ubertragbarkeit der Herzenwirkung X. Uber das Schicksal des Vagusstoffes. Arch. Ges. Physiol. 1926, 214:678.
88. London L., Thompson M.L., Sacks S., Fuller B., Bachman O.M., Myers J.E. Repeatability and validity of a field kit for estimation of cholinesterase in whole blood. Occup. Environ. Med. 1995, 52:57-64.
89. Loof I. Experience with the Ellman method: Proposal for a modification and an alternative method (PAP). U.S. Environmental Protection Agency (EPA) Workshop on Cholinesterase Methodologies 1992, 119-139. Office of Pesticide Programs, U.S. Environmental Protection Agency, Washington, DC.
90. Magnotti R.A., Eberly J.P. Test-mate ChE: New simplified cholinesterase assay system. Med. Def. Biosci. Rev. Proc. 1996, 3:1192-1201.
91. Magnotti R.A., Dowling K., Eberly J.P., McConnell R.S. Field measurement of plasma and erythrocyte cholinesterases. Clin. Chim. Acta 1988, 176(3):315-332.
92. Marchot P., Bourne Y., Prowse C.N., Bougis P.E., Taylor P. Inhibition of mouse acetylcholinesterase by fasciculin, crystal structure of the complex and mutagenesis of fasciculin. Toxicon 1998, 36:1613-1622.
93. Massoulie J., Pezzementi L., Bon S., Krejci E., Vallette F.M. Molecular and cellular biology of cholinesterases. Prog. Neurobiol. 1993, 41:31-91.
94. Massoulie J., Anselmet A., Bon S., Krejci E., Legay C., Morel N., Simon S. The polymorphism of acetylcholinesterase post-translational processing, quaternary associations and localization. Chem. Biol. Interac. 1999, 119/120:29-42.
95. McGehee D.S., Krasowski M.D., Fung D.L., Wilson B., Gronert G.A., Moss J. Cholinesterase inhibition by potato glycoalkaloids slows mivacurium metabolism. Anesthesiology 2000, 93:510-519.
96. Meshul C.K. Calcium channel blocker reverses anticholinesterase-induced myopathy. Brain Res. 1989, 497:142-168.
97. Metcalf R.L. The colorimetric microestimation of human blood cholinesterases and its application to poisoning by organic phosphate insecticides. J. Econ. Entomol. 1951, 44:883-890.
98. Michel H.O. An electrometric method for the determination of red blood cell and plasma cholinesterase activity. J. Lab. Clin. Med. 1949, 34:1564-1568.
99. Mikalsen A., Andersen R.A., Alexander J. Use of ethopropazine and BW 284C51 as selective inhibitors for cholinesterases from various species. Comp. Biochem. Physiol. C Comp. Pharmacol. 1986, 83:447-449.
100. Mileson B.E., Chambers J.E., Chen W.L., Dettbarn W., Ehrich M., Eldefrawi A.T., Gaylor D.W., Hamernik K., Hodgson E., Karczmar A.G., Padilla S., Pope C.N., Richardson R.J., Saunders D.R., Sheets L.P., Sultatos L.G., Wallace K.B. Common mechanism of toxicity: A case study of organophosphorus pesticides. Toxicol. Sci. 1998, 41:8-20.
101. 50 values represent?. Toxicol. Appl. Pharmacol. 1998, 148:46-49.
102. Mosca A., Onelli E., Rosti E., Paleari R., Luzzana M., Imbimbo B.P. A patient-side technique for real-time measurement of acetylcholinesterase activity during monitoring of eptastigmine treatment. Ther. Drug Monitor 1995, 17:230-238.
103. Myers D.K. Studies on cholinesterase. Species variation in the specificity patterns of the pseudo-cholinesterase. Biochem. J. 1953, 55:67-69.
104. Nabb D.P., Whitfield F. Determination of cholinesterases by an automated pH stat method. Arch. Environ. Health 1967, 15:147-154.
105. Nachmansohn D., Wilson I.B. The enzymic hydrolysis and synthesis of acetylcholine. Adv. Enzymol. 1951, 12:259-339.
106. Nagata K., Huang C.S., Song J.H., Narahashi T. Direct actions of anticholinesterases on the neuronal nicotinic acetylcholine receptor channels. Brain Res. 1997, 769:211-218.
107. National Academy of Sciences. (1999). "Review of the U.S. Army's Health Risk Assessments for Oral Exposure to Six Chemical-Warfare Agents" (R. Snyder, ed.). National Academy Press, Washington, DC.
108. Nigg H.N., Knaak J.B. Blood cholinesterase as human biomarkers of organophosphorus pesticide exposure. Rev. Environ. Contamin. Toxicol. 2000, 163:29-111.
109. Nigg H.N., Ramos L.E., Graham E.M., Sterling J., Brown S., Cornell J.A. Inhibition of human plasma and serum butyrylcholinesterase (EC 3.1.1.8) by alpha-chaconine and alpha solanine. Fundam. Appl. Pharmacol. 1996, 33:272-281.
110. Nordberg A., Svensson A.L. Cholinesterase inhibitors in the treatment of Alzheimer's disease: A comparison of tolerability and pharmacology. Drug Saf. 1998, 19:465-480.
111. Nostrandt A.C., Duncan J.A., Padilla S. A modified spectrophotometric method appropriate for measuring cholinesterase activity in tissue from carbaryl-treated animals. Fundam. Appl. Toxicol. 1993, 21:196-203.
112. O'Brien R.D. Insecticides, Actions and Metabolism 1967, Academic Press, New York, p. 83.
113. Okabe H., Sagesaka K., Nakajima N., Noma A. New enzymatic assay of cholinesterase activity. Clin. Chim. Acta 1977, 80:87-94.
114. Oliveira G.H., Henderson J.D., Wilson B.W. Cholinesterase measurements with an automated kit. Am. J. Ind. Med Suppl. 2002, 2:49-53.
115. Orwell G. Animal Farm; A Fairy Story 1945, Seeker & Warburg, London.
116. Patocka J. Huperzine A - An interesting anticholinesterase compound from the Chinese herbal medicine. Acta Med. (Hradec Kralove) 1998, 41(4):155-157.
117. Paulus J.-M., Maigne J., Keyhani E. Mouse megakaryocytes secrete acetylcholinesterase. Blood 1981, 58:1100-1106.
118. Pezzementi L., Sutherland D., Sanders M., Soong W., Milner D., McClellan J.S., Sapp M., Coblentz W.B., Rulewicz G., Merritt S. Structure and function of cholinesterases from agnathans and cephalochordates: Implications for the evolution of cholinesterases. Structure and Function of Cholinesterases and Related Proteins 1998, 105-110. Plenum, New York. B.P. Doctor (Ed.).
119. Polhuijs M., Langenberg J.P., Benschop H.P. New method for retrospective detection of exposure to organophosphorus anticholinesterases: Application to alleged sarin victims of Japanese terrorists. Toxicol. Appl. Pharmacol. 1997, 146:156-161.
120. Polhuijs M., Langenberg J.P., Noort D, Hulst A.G., De Jong L.P.A. Retrospective detection of exposure to organophosphates: Analyses in blood of human beings and rhesus monkeys. NBC Risks: Current Capabilities and Future Perspectives for Protection", 1999, Vol. 25:513-521. Kluwer, Dordrecht, The Netherlands, NATO Science Series 1.
121. Pope C.N. Organophosphorus pesticides: Do they all have the same mechanism of toxicity?. J. Toxicol. Environ. Health. B Crit. Rev. 1999, 2:161-181.
122. Potter W.T., Garry V.F., Kelly J.T., Tarone R., Griffith J., Nelson R.L. Radiometric assay of red cell and plasma cholinesterase in pesticide appliers from Minnesota. Toxicol. Appl. Pharmacol. 1993, 119:150-155.
123. Prall Y.G., Gambhir K.K., Ampy F.R. Acetylcholinesterase, an enzymatic marker of human red blood cell aging. Life Sci. 1998, 63:177-184.
124. Raveh L., Cohen G., Grauer E., Alkali D., Chapman S., Kapon Y., Sahar R., Kadar T., Shapira S. Efficacy of prophylactic treatments against sarin poisoning in rats. Med. Def. Biosci. Rev. Proc. 1996, 1:539-547.
125. Reiner E., Rudolf V.S., Doctor B.P., Furlong C.E., Johnson M.K., Lotti M., Silman I., Taylor P. Esterases reacting with organophosphorus compounds. Chem. Biol. Interact. 1999, 119/120:1-619.
126. Rider J.A., Hodges J.L., Swader J., Wiggins A.D. Plasma and red cell cholinesterase in 800 "healthy" blood donors. J. Lab. Clin. Med. 1957, 50:376-383.
127. Robitzki A., Mack A., Hoppe U., Chatonnet A., Layer P.G. Regulation of cholinesterase gene expression affects neuronal differentiation as revealed by transfection studies on reaggregating embryonic chicken retinal cells. Eur. J. Neurosci. 1997, 9:2394-2405.
128. Rocha E.S., Swanson K.L., Aracava Y., Goolsby J.E., Maelicke A., Albuquerque E.X. Paraoxon, cholinesterase-independent stimulation of transmitter release and selective block of ligand-gated ion channels in cultured hippocampal neurons. J. Pharmacol. Exp. Ther. 1996, 278:1175-1187.
129. Rodgers K., Xiong S. Effect of administration of malathion for 14 days on macrophage function and mast cell degranulation. Fundam. Appl. Toxicol. 1997, 37:95-99.
130. Rodgers K.E., Ellefson D.D. Modulation of respiratory burst activity and mitogenic response of human peripheral blood mononuclear cells and murine splenocytes and peritoneal cells by malathion. Fundam. Appl. Toxicol. 1990, 14:309-317.
131. Rogers K.R., Cao C.J., Valdes J.J., Eldefrawi A.T., Eldefrawi M.E. Acetylcholinesterase fiber-optic biosensor for detection of anticholinesterases. Fundam. Appl. Toxicol. 1991, 16:810-820.
132. Chemical Warfare Agents 2008, CRC Press, Boca Raton, FL. 2nd ed. J.A. Romano, B.J. Lukey, H. Salem (Eds.).
133. Rosenberry T.L., Mallender W.D., Thomas P.J., Szegletes T. Substrate binding to the peripheral site occurs on the catalytic pathway of acetylcholinesterase and leads to substrate inhibition. Structure and Function of Cholinesterases and Related Proteins 1998, 189-196. Plenum, New York. B.P. Doctor (Ed.).
134. Ryhanen R., Narhi M., Puhakainen E., Hanninen O., Kontturi-Narhi V. Pseudocholinesterase activity and its origin in human oral fluid. J. Dental Res. 1983, 62:20-23.
135. Sanz P., Rodriguez-Vicente M.C., Diaz D., Repetto J., Repetto M. Red blood cell and total acetylcholinesterase and plasma pseudocholinesterase in humans: Observed variances. Clin. Toxicol. 1991, 29:81-90.
136. Senanayake N., Karalliedde L. Neurotoxic effects of organophosphorus insecticides. An intermediate syndrome. N. Engl. J. Med. 1987, 316:761-763.
137. Sharma K.V., Bigbee J.W. Acetylcholinesterase antibody treatment results in neurite detachment and reduced outgrowth from cultured neurons: Further evidence for a cell adhesive role for neuronal acetylcholinesterase. J. Neurosci. Res. 1998, 53:454-464.
138. Shih D.M., Gu L., Xia Y.-R., Navab M., Li W.-F., Hama S., Castellani L.W., Furlong C.E., Costa L.G., Fogelman A.M., Lusis A.J. Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis. Nature (London) 1998, 394:284-287.
139. Sidell F.R., Kamiskis A. Temporal intrapersonal physiological variability of cholinesterase activity in human plasma and erythrocytes. Clin. Chem. 1975, 21:1961-1963.
140. Cholinesterase (PTC) Procedure No. 422 1989, Sigma Diagnostics, Sigma Diagnostics, St. Louis.
141. Silk E., King J., Whittaker M. Assay of cholinesterase in clinical chemistry. Ann. Clin. Biochem. 1979, 16:57-75.
142. Silman I., Sussman J.L. Structural and functional studies on acetylcholinesterase: A perspective. Structure and Function of Cholinesterases and Related Proteins 1998, 25-33. Plenum, New York. B.P. Doctor (Ed.).
143. Silman I., Sussman J.L. Acetylcholinesterase: How is structure related to function?. Chem. Biol. Interact. 2008, 175(1-3):3-10.
144. Silver A., The Biology of Cholinesterases: Frontiers of Biology 1974, Vol. 36. North-Holland, Amsterdam.
145. Sket D., Dettbarn W.-D., Clinton M.E., Misulis K.E., Sketelj J., Cucke D., Brizin M. Prevention of diisopropylphosphorofluoridate-induced myopathy by botulinum toxin type A blockage of quantal release of acetylcholine. Acta Neuropathol. 1991, 82:134-142.
146. Spencer P.S., Schaumburg H.H., Ludolph A.C. Experimental and Clinical Neurotoxicology 2000, Oxford University Press, New York. 2nd ed.
147. Sperling L.E., Steinert G., Boutter J., Landgraf D., Hescheler J., Pollet D., Layer P.G. Characterisation of cholinesterase expression during murine embryonic stem cell differentiation. Chem. Biol. Interact. 2008, 175(1-3):156-160.
148. Sussman J.L., Harel M., Frolow F., Oefner C., Goldman A., Toker L., Silman I. Atomic structure of acetylcholinesterase from Torpedo californica: A prototypic acetylcholine-binding protein. Science 1991, 253:872-879.
149. Talesa V., Grauso M., Arpagaus M., Giovannini E., Romani R., Rosi G. Molecular cloning and expression of a full-length cDNA encoding acetylcholinesterase in optic lobes of the squid Loligo opalescens, a new member of the cholinesterase family resistant to diisopropyl fluorophosphate. J. Neurochem. 1999, 72(3):1250-1258.
150. Taylor P. The cholinesterases: From genes to proteins. Annu. Rev. Pharmacol. Toxicol. 1994, 34:281-320.
151. Taylor P. Cholinesterase agents. Goodman and Gilman's the Pharmacological Basis of Therapeutics 1996, 161-176. McGraw-Hill, New York. 9th ed. J.G. Hardman (Ed.).
152. Taylor P. Esterases reacting with organophosphorus compounds. Chem. Biol. Interact. 1999, 119/120:1-620.
153. Thomsen T., Kewitz H., Pleul O. Estimation of cholinesterase activity (EC 3.1.17; 3.1.1.8) in undiluted plasma and erythrocytes as a tool for measuring in vivo effects of reversible inhibitors. J. Clin. Chem. Clin. Biochem. 1988, 26:469-475.
154. Thomsen T., Kewitz H., Pleul O. A suitable method to monitor inhibition of cholinesterase activities in tissues as induced by reversible enzyme inhibitors. Enzyme 1989, 42:219-224.
155. Thyssen J., Machemer L. Imidacloprid: toxicology and metabolism. Nicotinoid Insecticides and the Nicotinic Acetylcholine Receptor 1999, 213-222. Springer, Tokyo. I. Yamamoto, J.E. Casida (Eds.).
156. Traina M.E., Serpietri L.A. Changes in the levels and forms of rat plasma cholinesterases during chronic diisopropylphosphofluoridate intoxication. Biochem. Pharmacol. 1984, 33:645-653.
157. Tuovinen K., Kaliste-Korhonen E., Raushel F.M., Hanninen O. Success of pyridostigmine, physostigmine, eptastigmine and phosphotriesterase treatments in acute sarin intoxication. Toxicology 1999, 134:169-178.
158. Workshop on Cholinesterase Methodologies 1992, U.S. Environmental Protection Agency (EPA), Office of Pesticide Programs, U.S. EPA, Washington, DC.
159. van den Beukel I., van Kleef R.G., Oortgissen M. Differential effects of physostigmine and organophosphates on nicotinic receptors in neuronal cells of different species. Neurotoxicology 1998, 19:777-787.
160. 1-dithiodinicotinic acid as a chromogen in the Ellman method for cholinesterase determinations. Vet. Hum. Toxicol. 1996, 38:249-253.
161. Wills J.H. The measurement and significance of changes in the cholinesterase activities of erythrocytes and plasma in man and animals. CRC Crit. Rev. Toxicol. 1972, 1:153-199.
162. Wilson B.W. Cholinesterases. Clinical Chemistry of Laboratory Animals 1999, 430-440. Taylor & Francis, Philadelphia. 2nd ed. E. Quimby, W. Loeb (Eds.).
163. Wilson I.B., Ginsburg S. A powerful reactivator of alkyl phosphate-inhibited acetylcholinesterase. Biochim. Biophys. Acta 1955, 18:168-170.
164. Wilson B.W., Henderson J.D. Blood esterase determinations as markers of exposure. Rev. Environ. Contam. Toxicol. 1992, 128:55-69.
165. Wilson B.W., Henderson J.D. Determination of cholinesterase in blood and tissue. Curr. Protocols Toxicol. 2007, (Suppl. 34):1-16.
166. Proceedings of the U.S. EPA Workshop on Cholinesterase Methodologies, Arlington, VA, Dec. 4-5, 1991 1992, Office of Pesticide Programs, U.S. Environmental Protection Agency, Washington, DC. B.W. Wilson, B. Jaeger, K. Baetcke (Eds.).
167. Wilson B.W., Hooper M.J., Hansen M.E., Nieberg P.S. Reactivation of organophosphate inhibited AChE with oximes. Organophosphates: Chemistry, Fate, and Effects 1992, 107-137. Academic Press, New York. J.E. Chambers, P.E. Levi (Eds.).
168. Wilson B.W., Padilla S., Henderson J.D. Factors in standardizing automated cholinesterase assays. J. Toxicol. Environ. Health 1996, 48:187-195.
169. Wilson B.W., Sanborn J.R., O'Malley M.A., Henderson J.D., Billitti J.R. Monitoring the pesticide-exposed worker. Occup. Med. 1997, 12:347-363.
170. Wilson B.W., McCurdy S.A., Henderson J.D., McCarthy S.A., Billitti J.E. Cholinesterases and agriculture, humans, laboratory animals and wildlife. Structure and Function of Cholinesterases and Related Proteins 1998, 539-546. Plenum, New York. B.P. Doctor (Ed.).
171. Wilson, B. W., Henderson, J. D., Bosworth, D. H., and Oliveira, G. H. (2000). "Standardization of cholinesterase measurements for monitoring human exposures". Book of Abstracts. 219th ACS National Meeting, San Francisco, CA, March 26-30.
172. Wilson B.W., Henderson J.D., Furman J.L., Zeller B.E., Michaelson D. Blood cholinesterases from Washington State orchard workers. Bull. Environ. Contam. Toxicol. 2009, 83(1):59-61.
173. Witter R.F. Measurement of blood cholinesterase. Arch. Environ. Health, 1963, 6:537-563.
174. Wolfe A.D., Rush R.S., Doctor B.P., Koplovitz I., Jones D. Acetylcholinesterase prophylaxis against organophosphate toxicity. Fundam. Appl. Toxicol. 1987, 9:266-270.
175. Wright C.I., Sabine J.C. Cholinesterases of human erythrocyte and plasma and their inhibition by antimalarial drugs. J. Pharmacol. 1948, 93:230-239.
176. Wyttenbach C.R., Thompson S.C. The effects of the organophosphate insecticide malathion on very young chick embryos, malformations
177. Xie W., Stribley J.A., Chatonnet A., Wilder P.J., Rizzino A., McComb R.D., Taylor P., Hinrichs S.H., Lockridge O. Postnatal developmental delay and supersensitivity to organophosphate in gene-targeted mice lacking acetylcholinesterase. J. Pharmacol. Exp. Ther. 2000, 293(3):896-902.
178. Yamalik N., Ozer N., Caglayan F., Caglayan G. Determination of pseudocholinesterase activity in the gingival crevicular fluid, saliva, and serum from patients with juvenile periodontitis and rapidly progressive periodontitis. J. Dental Res. 1990, 69:87-89.
179. Yeary R.A., Eaton J., Gilmore E., North B., Singell J. A multiyear study of blood cholinesterase activity in urban pesticide applicators. J. Toxicol. Environ. Health 1993, 39:11-25.
180. Yuknavage K.L., Fenske R.A., Kalman D.A., Keifer M.C., Furlong C.E. Simulated dermal contamination with capillary samples and field cholinesterase biomonitoring. J. Toxicol. Environ. Health 1997, 51:35-55.
181. Zajicek J. Studies on the histogenesis of blood platelets and megakaryocytes. Acta Physiol. Scand. 1957, 40(Suppl. 138):1-32.